Description
Retatrutide research peptide
Retatrutide is an investigational single peptide that activates three receptors: GIP, GLP-1 and glucagon. It is one of the most closely watched compounds in current metabolic research.
Product details
| Compound | Retatrutide |
|---|---|
| Class | Triple GIP / GLP-1 / glucagon receptor agonist |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What research has examined
- Triple agonism: combined incretin and glucagon receptor signalling.
- Clinical programme: phase 2 results published in the New England Journal of Medicine and ongoing phase 3 trials.
- Comparative research: benchmarking against single and dual agonists.
For background, compare semaglutide and cagrilintide.
Regulatory status
This compound is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.